Implanet accelerated its commercialization strategy for cobotic solutions in orthopedic surgery with the signing of an exclusive distribution agreement with TINAVI Medical for the TiRobot spine surgery system.
This commercial partnership between Implanet and Tinavi will enable the synergy of both groups’ technological and R&D expertise. It strengthens Implanet’s product offering by incorporating the latest advances and innovations in spine surgery (including deformity treatment systems, minimally invasive ranges, robotics, and artificial intelligence, etc.).
The TiRobot is an autonomous cobot that is not fixed to the operating table, allowing the surgeon to make continuous adjustments throughout the procedure according to surgical needs and patient movements. TiRobot provides an automated guidance system during surgery and can address most spinal pathology indications. Future updates will soon enable its use in other orthopedic surgical specialties, such as hip, knee, and shoulder prosthesis implantation, as well as in trauma surgery.
Ludovic Lastennet, Implanet’s Chief Executive Officer, stated: “Following our partnership with Sanyou Medical and in line with our strategic plan, the signing of this exclusive distribution agreement with TINAVI Medical Technologies, a Chinese manufacturer and leading player in surgical robotics, strengthens Implanet’s positioning as a provider of comprehensive solutions for spine surgeons. This agreement also paves the way for the next stages in autonomous surgeon-assistance technologies, enabling more precise, faster procedures while enhancing patient safety.”
Implanet accelerated its commercialization strategy for cobotic solutions in orthopedic surgery with the signing of an exclusive distribution agreement with TINAVI Medical for the TiRobot spine surgery system.
This commercial partnership between Implanet and Tinavi will enable the synergy of both groups’ technological and R&D expertise. It...
Implanet accelerated its commercialization strategy for cobotic solutions in orthopedic surgery with the signing of an exclusive distribution agreement with TINAVI Medical for the TiRobot spine surgery system.
This commercial partnership between Implanet and Tinavi will enable the synergy of both groups’ technological and R&D expertise. It strengthens Implanet’s product offering by incorporating the latest advances and innovations in spine surgery (including deformity treatment systems, minimally invasive ranges, robotics, and artificial intelligence, etc.).
The TiRobot is an autonomous cobot that is not fixed to the operating table, allowing the surgeon to make continuous adjustments throughout the procedure according to surgical needs and patient movements. TiRobot provides an automated guidance system during surgery and can address most spinal pathology indications. Future updates will soon enable its use in other orthopedic surgical specialties, such as hip, knee, and shoulder prosthesis implantation, as well as in trauma surgery.
Ludovic Lastennet, Implanet’s Chief Executive Officer, stated: “Following our partnership with Sanyou Medical and in line with our strategic plan, the signing of this exclusive distribution agreement with TINAVI Medical Technologies, a Chinese manufacturer and leading player in surgical robotics, strengthens Implanet’s positioning as a provider of comprehensive solutions for spine surgeons. This agreement also paves the way for the next stages in autonomous surgeon-assistance technologies, enabling more precise, faster procedures while enhancing patient safety.”
Copy to clipboard 
